Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evgeniy Eruslanov

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|January 15, 2010
Identification of ROS using oxidized DCFDA and flow-cytometryEvgeniy Eruslanov, Sergei Kusmartsev
American Journal of Translational Research|November 13, 2012
Tumor-associated macrophages: function, phenotype, and link to prognosis in human lung cancerJon G Quatromoni, Evgeniy Eruslanov
Nature Immunology|January 2, 2025
The heterogeneity of neutrophils in cancer and its implication for therapeutic targetingEvgeniy Eruslanov, Yulia Nefedova, Dmitry I Gabrilovich
Cancer Immunology, Immunotherapy : CII|November 3, 2009
Generation of antigen-presenting cells from tumor-infiltrated CD11b myeloid cells with DNA demethylating agent 5-aza-2'-deoxycytidineIrina Daurkin, Evgeniy Eruslanov, Johannes Vieweg, et al.
Journal of Leukocyte Biology|July 1, 2010
Pivotal Advance: Tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE₂ catabolism in myeloid cellsEvgeniy Eruslanov, Irina Daurkin, Javier Ortiz, et al.
International Immunopharmacology|February 15, 2011
Aberrant PGE₂ metabolism in bladder tumor microenvironment promotes immunosuppressive phenotype of tumor-infiltrating myeloid cellsEvgeniy Eruslanov, Irina Daurkin, Johannes Vieweg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2009
Altered expression of 15-hydroxyprostaglandin dehydrogenase in tumor-infiltrated CD11b myeloid cells: a mechanism for immune evasion in cancerEvgeniy Eruslanov, Sergei Kaliberov, Irina Daurkin, et al.
Journal of Leukocyte Biology|November 1, 2014
An optimized disaggregation method for human lung tumors that preserves the phenotype and function of the immune cellsJon G Quatromoni, Sunil Singhal, Pratik Bhojnagarwala, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2008
Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinomaSergei Kusmartsev, Zhen Su, Axel Heiser, et al.
Frontiers in Immunology|September 5, 2024
Antisense targeting of FOXP3+ Tregs to boost anti-tumor immunityTatiana Akimova, Liqing Wang, Zhanna Bartosh, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Methods in Molecular Biology (Clifton, N.J.)|January 15, 2010
Identification of ROS using oxidized DCFDA and flow-cytometryEvgeniy Eruslanov, Sergei Kusmartsev
American Journal of Translational Research|November 13, 2012
Tumor-associated macrophages: function, phenotype, and link to prognosis in human lung cancerJon G Quatromoni, Evgeniy Eruslanov
Nature Immunology|January 2, 2025
The heterogeneity of neutrophils in cancer and its implication for therapeutic targetingEvgeniy Eruslanov, Yulia Nefedova, Dmitry I Gabrilovich
Cancer Immunology, Immunotherapy : CII|November 3, 2009
Generation of antigen-presenting cells from tumor-infiltrated CD11b myeloid cells with DNA demethylating agent 5-aza-2'-deoxycytidineIrina Daurkin, Evgeniy Eruslanov, Johannes Vieweg, et al.
Journal of Leukocyte Biology|July 1, 2010
Pivotal Advance: Tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE₂ catabolism in myeloid cellsEvgeniy Eruslanov, Irina Daurkin, Javier Ortiz, et al.
International Immunopharmacology|February 15, 2011
Aberrant PGE₂ metabolism in bladder tumor microenvironment promotes immunosuppressive phenotype of tumor-infiltrating myeloid cellsEvgeniy Eruslanov, Irina Daurkin, Johannes Vieweg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2009
Altered expression of 15-hydroxyprostaglandin dehydrogenase in tumor-infiltrated CD11b myeloid cells: a mechanism for immune evasion in cancerEvgeniy Eruslanov, Sergei Kaliberov, Irina Daurkin, et al.
Journal of Leukocyte Biology|November 1, 2014
An optimized disaggregation method for human lung tumors that preserves the phenotype and function of the immune cellsJon G Quatromoni, Sunil Singhal, Pratik Bhojnagarwala, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2008
Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinomaSergei Kusmartsev, Zhen Su, Axel Heiser, et al.
Frontiers in Immunology|September 5, 2024
Antisense targeting of FOXP3+ Tregs to boost anti-tumor immunityTatiana Akimova, Liqing Wang, Zhanna Bartosh, et al.
Pageof 4